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Mapping to Quality of Life and Capability
Measures in Cataract Surgery Patients:
From Cat-PROM5 to EQ-5D-3L,
EQ-5D-5L, and ICECAP-O Using
Mixture Modelling
Padraig Dixon , William Hollingworth, and John Sparrow
Objectives. Cataract is a prevalent and potentially blinding eye condition. Cataract surgery, the only proven treat-
ment for this condition, is a very frequently undertaken procedure. The objective of this analysis was to develop a
mapping algorithm that could be used to predict quality of life and capability scores from the Cat-PROM5, a newly
developed, validated patient-reported outcome measure for patients undergoing cataract surgery. Methods. We esti-
mated linear models and adjusted limited dependent variable mixture models. Data were taken from the Predict-
CAT cohort of up to 1181 patients undergoing cataract surgery at two sites in England. The Cat-PROM5 was
mapped to two quality of life measures (EQ-5D-3L and EQ-5D-5L) and one capability measure (ICECAP-O). All
patients reported ICECAP-O and one or other of the EQ-5D measures both before and after cataract surgery.
Model performance was assessed using likelihood statistics, graphical inspections of model fit, and error measure-
ments. Results. Adjusted limited dependent variable mixture models dominated linear models on all performance cri-
teria. Mixture models offered very good fit. Three component models that allowed component membership to be a
function of covariates (age, sex, and diabetic status depending on specification and outcome measure) and which con-
ditioned on covariates offered the best performance in almost all cases. An exception was the EQ-5D-5L post-surgery
for which a two-component model was selected. Conclusions.Mapping from Cat-PROM5 to quality of life and capa-
bility measures using adjusted limited dependent variable mixture models is feasible, and the estimates can be used to
support cost-effectiveness analysis in relation to cataract care. Mixture models performed strongly for both quality of
life outcomes and capability outcomes.
Keywords
Cat-PROM5 mixture models, cataract, EQ-5D, ICECAP, mapping, quality of life
Date received: May 28, 2019; accepted: February 6, 2020
Introduction
Cataract, the clouding of the lens of the eye, is a prevalent
and potentially blinding age-related condition. Cataract
surgery is the only proven treatment for the condition and
is the most frequently undertaken surgical procedure on
the National Health Service (NHS)1 and in many other
international health systems.2 Almost 400,000 cataract sur-
geries are performed annually in England.3 The aim of this
study was to map scores from a newly created self-report
questionnaire for cataracts (the Cat-PROM5—cataract
patient-reported outcome measure2) to generic, preference-
based quality of life (Euroqol EQ-5D questionnaire4 in
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both the three-level [EQ-5D-3L5] and five-level [EQ-5D-
5L6] versions) and capability (ICEpop CAPability measure
for Older people questionnaire7 [ICECAP-O]) measures.
Mapping is the expression of values from one ques-
tionnaire, scale, or instrument in terms of another.
Mapping can be used to facilitate analyses that may
require estimates of generic utility and capability scores
in settings where (in this case) only the Cat-PROM5
instrument was used. Clinical studies may wish to avoid
imposing a burden on patients to complete both a
disease-specific questionnaire such as Cat-PROM5 and
generic measures. There may be administrative or finan-
cial costs associated with administering multiple instru-
ments that dispose researchers to limit the volume of
data collected. These considerations are particularly rele-
vant to cataract surgery—given the exceptionally high
volume of this surgical procedure, the cost and burden of
administering more than one questionnaire before and after
surgery is likely to be prohibitive in most circumstances.
A growing interest in mapping is reflected in the
increasing volume of applied analyses,8–10 methodological
work,10 guideline development,11,12 and reliance on map-
ping in health technology appraisal submissions to the
National Institute for Health and Care Excellence.13,14
Data
The Predict-CAT study
Predict-CAT was a prospective cohort study, the key
objective of which was the quantification of risk indica-
tors for favorable and unfavorable outcomes in typical
National Health Service (NHS) patients who were candi-
dates for cataract surgery. Potential participants in the
cohort were identified at the time of listing for cataract
surgery, or from preoperative assessment patient lists.2
The study was undertaken at two NHS sites in the south
of England: Bristol Eye Hospital and Gloucestershire
Hospitals NHS Foundation Trust. The patient pathway
at both trusts was managed as for routine cataract care.
Patients willing to participate in the study were eligible
for inclusion if they were aged at least 50 years at recruit-
ment, were approaching first or second eye cataract sur-
gery, were capable of providing informed consent, were
willing to participate, and could understand and com-
plete versions of the Cat-PROM questionnaire, versions
of the Euroqol EQ-5D questionnaire,4 and the ICECAP-
O (ICEpop CAPability measure for Older people) ques-
tionnaire.7 These questionnaires are described in more
detail below. Patients who failed to meet entry criteria,
and/or who were undergoing certain types of prespecified
eye operation (such as combined phako-trabeculectomy),
were not eligible for inclusion.
Data Collection, and the Cat-PROM5
Instrument
Data from the Predict-CAT study cohort was used as the
sole source of the estimation sample. Participant data were
obtained on two occasions: preoperatively for a baseline
assessment and postoperatively for a follow-up assessment.
At baseline, height, weight and diabetic status were
assessed, and participants reported other health, demo-
graphic, and socioeconomic data. All participants completed
Cat-PROM5 and capability (ICECAP-O) questionnaires
and were randomized (1:1:1) to receive one of three quality
of life questionnaires: either EQ-5D-3L,5 EQ-5D-3L with
vision ‘‘bolt-on,’’10 or EQ-5D-5L.6 We did not map to the
EQ-5D-3L with vision ‘‘bolt-on’’ questionnaire due to the
infrequent use of that questionnaire and unclear relevance
to the calculation of quality-adjusted life years. A full ocular
examination and slit lamp assessment was undertaken on all
participants.
Follow-ups were scheduled to take place 6 to 8 weeks
after cataract surgery, although there was some variation
in when these actually took place. On confirmation of
continuing eligibility, participants described any changes
in clinical details, underwent a full ocular examination,
and again completed the Cat-PROM5 and quality of life
questionnaires administered at baseline.
The Cat-PROM5 Instrument
The CatPROM-5 instrument was designed as a short
questionnaire to measure the self-reported impact of
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cataracts on vision and quality of life.2 It has just five
items: whether vision overall has been affected by the
‘‘bad’’ eye, the extent to which eyesight has interfered
with life in general, a rating of vision overall, the fre-
quency with which vision prevented usual activities, and
difficulties in reading normal print in books or newspa-
pers. The recall period for all questions is ‘‘the past
month.’’ The instrument is responsive and good psycho-
metric properties have been demonstrated.2
The EQ-5D-3L and EQ-5D-5L Measures
The EQ-5D measure is a standardized, preference-based,
generic questionnaire that facilitates the measurement
and valuation of health-related quality of life. The EQ-
5D measures five dimensions of health-related quality of
life: mobility, self-care, capacity to undertake usual activ-
ities, pain and discomfort, and anxiety and depression.
The EQ-5D-3L4 instrument measures three categories
of response to questions on each of these dimensions.
The responses may be described as follows: no problems,
some problems, and extreme problems. The EQ-5D-5L6
instrument encompasses the same five domains, but
allows respondents to report five rather than three cate-
gories of response: no problems, slight problems, moder-
ate problems, severe problems, and extreme problems.
Responses to EQ-5D questionnaires can be converted
into a single index utility score that is anchored on 1 for
perfect health and 0 for death. Negative values represent
health profiles considered to be worse than death, to a
minimum under the English valuation set of 20.594 for
EQ-5D-3L5 and 20.285 for EQ-5D-5L.6
The ICECAP-O Questionnaire
The ICECAP-O questionnaire measures ‘‘capability’’ in
older people. Capability is intended to reflect a broader
sense of well-being than may be captured by the notion
of ‘‘health’’ alone. The instrument has five attributes:
attachment, security, role, enjoyment, and control. Each
attribute has four levels. For example, the control attri-
bute is intended to reflect independence, and its statements
range from ‘‘I am able to be completely independent’’
to ‘‘I am unable to be at all independent.’’ Valuations
for the questionnaire were obtained from a best-worst
scaling exercise conducted among older people living in
England.15 The index value has a theoretical range
from 0 (lowest possible value reflecting low capability)
to 1, reflecting high capability.
Methods for Quantitative Analysis
Best Practice in Methods for Mapping Analyses
Our objective was to map responses from the Cat-PROM5
instrument to EQ-5D-3L, EQ-5D-5L, and ICECAP-O
questionnaires. Our approach to the selection of specific
methods was guided by recommendations12,16 in best prac-
tice for mapping set out in an expert consensus report on
mapping. We also report our methods and findings follow-
ing the ‘‘preferred items’’ checklist of Petrou et al.,17 a com-
pleted version of which is available in the supplementary
material. We consider recommendations for model selec-
tion below under specific headings.
Empirical Performance of Methods for
Mapping Analysis
Recent evidence18–26 suggests that a class of direct map-
ping algorithms that uses adjusted limited dependent
variable mixture modelling offers advantages over other
types of mapping methods, particularly when utility dis-
tributions are skewed and multimodal. We discuss these
methods in more detail below, following further consid-
eration of the Wailoo et al. criteria12,16 for best practice
in mapping. We note in passing that indirect mapping
could not be undertaken for the Predict-CAT cohort
given zero or limited responses to some categories of
both EQ-5D-3L and EQ-5D-5L
Good Statistical Practice in Mapping
A critical rationale for mapping functions is to accurately
predict, in a variety of datasets, health state utility values
of the target instrument.27 The accuracy of predictions
can be understood, in broad terms, as a measure of the
‘‘fit’’ between the model’s predicted utility values and the
utility values reported by respondents. We relied on a
variety of criteria as follows.
Summary measures of fit, such as the root mean
squared error (RMSE), mean absolute error (MAE), and
ranges of predictions are frequently reported in mapping
analyses27 and offer helpful but partial and potentially
insensitive characterizations of model fit.12 Information
criteria that tradeoff between model fit and parsimony
by penalizing the inclusion of additional covariates offer
a means of choosing between likelihood-based models.
We calculated for each model the Akaike Information
Criterion (AIC) and the Bayesian Information Criterion
(BIC); lower values for each criterion are preferred to
higher values.
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We also used less formal but potentially informative
tools such as assessing face validity and graphical com-
parisons of plots of actual and predicted quality of life
and capability values, and comparisons of actual and
predicted values across the distribution of observed
values.
Covariate Selection
Two important but potentially conflicting issues are rele-
vant to the a priori choice of the covariate set.12 The first
is that the exclusion of covariates risks misspecification
of the mapping model, subject to the proviso that corre-
lated covariates need not be included in the interests of
parsimony. The second issue is that of overfitting, an
important consideration given the relatively modest size
of our cohort.
Age and sex are associated with quality of life in gen-
eral,28–30 and with the Cat-PROM5 instrument in the
Predict-CAT cohort. Age and sex are correlated with
other available covariates, are likely to be available in
most other datasets to which the mapping algorithm
developed here may be applied, and are frequently used
in mapping algorithms of the type developed here.
Nonlinear terms in age did not improve the predictive
performance of any studied model in initial modelling.
Diabetes is associated with decrements to utility in gen-
eral29,30 and in this cohort (e.g., diabetic participants had
baseline mean EQ-5D-3L values about 0.06 points lower
than non-diabetic participants), and is a risk factor for
cataract.31,32 Age, sex, and diabetic status were therefore
retained as covariates.
External Validation of Algorithms
No other sources of data were available given the ab
initio creation of the Cat-PROM5 instrument during an
earlier phase of this research program. The pre- and
postscores were not good candidates for validation as
the distributions of utility and capability scores were sub-
stantially different in the pre- and postoperative settings
(see in particular Figures 1 to 4). This means that a map-
ping algorithm that worked well in the preoperative set-
ting may not have been well suited to the postoperative
context because of differences in the distributions in both
the source and target instruments. To avoid imposing a
single mapping algorithm across these distinct circum-
stances, we instead rely on validation by head-to-head
performance comparisons between types of estimators
and model specifications.12
Exploratory Data Analysis and Missing Data
We undertook exploratory data analysis by calculating
Spearman’s correlation coefficient, calculating summary
statistics, comparing ranges, and calculating EQ-5D and
ICECAP-O measures at different levels of the Cat-
PROM5 instrument. We retained individuals in the anal-
ysis sample if they had complete data at both baseline
and follow-up.
Models Estimated
We estimated two classes of mapping algorithms. The
first set of models used an adjusted limited dependent
variable, mixture modelling approach.18 We compared
these findings to simple linear models estimated using
ordinary least squares (OLS). Linear models estimated
using OLS were studied for two reasons. The first was to
provide a benchmark against which more complex mod-
els could be compared. The second was to assess whether
this estimator was capable of outperforming these other,
more complex models.
The use of mixtures of distributions readily permits
their range to be limited to reflect the minimum and max-
imum permitted values at feasible values of the UK or
English tariff for each of the quality of life and capability
questionnaires studied here. The distributions can also
model the ‘‘gap’’ between perfect health (EQ-5D-3L state
11111, index value = 1) and the next highest index value
in the EQ-5D distributions (‘‘some problems’’ with usual
activities, ‘‘no problems’’ on other dimensions EQ-5D-3L
state 11211, index value = 0.883). This is larger than any
other discontinuity in the UK valuation of EQ-5D-3L18
and may reflect the large perceived difference in utility
between the labels ‘‘no problems’’ and ‘‘some problems.’’
The discontinuity is still present, but much smaller on the
EQ-5D-5L (EQ-5D-5L 11111, index value = 1; EQ-5D-
5L 11211, index value = 0.951), which has more response
levels and uses the label ‘‘slight problems’’ to define the
first level of decrement in usual activities.
Membership of latent classes, which may give rise to
the familiar multimodal ‘‘peaks’’ in target distributions,
is given effect under the mixture modelling approach by
using multinomial logit models (for the probability of
latent class membership) that can include variables that
may affect the probability of class membership such as
age or sex. These latent classes were combined using
probability weights to generate a skewed and multimodal
distribution. There is no simple rule to determine how
many classes ought to be used, and a degree of judge-
ment is required.18
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We use finite mixtures of limited dependent variable
normal distributions to model the distributions of latent
classes. Beta-type models are an alternative,33 but are
computationally more expensive, require more para-
meters than mixtures of normal distributions, and were
not obviously well suited to the relatively modest sample
sizes available to us.
Approach to Model Development
The dependent variable in all regressions is an EQ-5D
index score (whether the EQ-5D-3L score or the EQ-5D-
5L score) or the ICECAP-O index score. All models
included the Cat-PROM5 summary index value. Model
fit and model convergence was not improved when
including the components of the Cat-PROM5 index in
initial modelling.
Mixture models with one component were dominated
by mixture models with more than one component.
Mixture models with four components almost never con-
verged. We therefore focused attention in all subsequent
modelling on two- or three-class component models. All
EQ-5D models explicitly incorporated the gap between
perfect health and the next highest possible value.
The results of mixture models can be sensitive to
model starting values. We tested several approaches to
the choice of starting values, given the sensitivity of mix-
ture models to these parameters. The approach adopted
was to first estimate a constant-only model, the para-
meters of which were then used as starting values for full
models. The exception was when modelling baseline EQ-
5D-3L using three components, for which the most stable
estimates were obtained by a search for starting values
using Stata’s inbuilt maximum likelihood algorithm. No
approach to starting values was found to produce conver-
gent values for the EQ-5D-3L outcome at follow-up.
Following these initial analyses, we explored mixture
models of increasing complexity. We started with simple
models with no covariates other than the Cat-PROM5
index score, and with fixed probabilities of component
membership. We then progressively extended these models
to include all single and joint combinations of sex, age, and
diabetic status as covariates, and as variables singly and
jointly influencing the probability of component member-
ship. For linear models, we initially considered models with
no covariates other than the Cat-PROM5 index value,
before estimating models including all combinations of sex,
age, and diabetic status as covariates.
All analysis was conducted using Stata version 15.1
(StataCorp: College Station, Texas). The mixture modelling
approach was implemented with the -aldvmm- package.21
Results
Complete data at both baseline and follow-up appoint-
ments were available from 1181 different participants of
whom 598 were women (51%). However, complete data
(both baseline and follow-up assessments) on target out-
come measures (both EQ-5D measures and ICECAP-O)
were not available for all of these individuals. Mean age
at baseline was 73.8 years (standard deviation: 8.2).
There were 226 (19%) diabetic participants at baseline.
Mean quality of life and capability were higher at
follow-up than at baseline, and the proportion of partici-
pants reporting ‘‘best’’ scores on all measures increased
(Table 1).
All quality of life and capability index values were
correlated with the Cat-PROM5 instrument with the
expected sign (Table 2)—better outcomes are associated
with a negative score on Cat-PROM5. P values were
\0.001 for all questionnaires at both time points.
Distributions of Source and Target Instruments
Figure 1 summarizes the distribution of Cat-PROM5 at
baseline and follow-up (n = 1186 at each time point).
This indicates an improvement in overall cataract-
related outcomes, confirming the improvements reported
Table 1 Summary Statistics
Baseline Follow-Up
EQ-5D-3L
(n = 396)
EQ-5D-5L
(n = 383)
ICECAP-O
(n = 1174)
CatPROM5
(n = 1181)
EQ-5D-3L
(n = 396)
EQ-5D-5L
(n = 383)
ICECAP-O
(n = 1174)
CatPROM5
(n = 1181)
Mean 0.76 0.83 0.86 20.31 0.80 0.85 0.89 23.20
SD 0.24 0.17 0.12 2.34 0.23 0.17 0.11 3.08
Minimum 20.18 20.1 0.16 29.18 20.08 20.13 0.16 29.18
Maximum 1.00 1.00 1.00 7.45 1.00 1.00 1.00 4.98
% of ‘‘best’’ values 26.5% 15.7% 9.7% 0.1% 38.6% 26.4% 15.4% 9.2%
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in Table 1, with a leftward shift in the index value of Cat-
PROM5 apparent at follow-up compared to baseline.
Figures 2 and 3 summarize baseline and follow-up EQ-
5D-3L (n = 396) and EQ-5D-5L (n = 383) index utilities.
Multimodality and gaps that are the classic features of
EQ-5D distributions.10,18 The distribution of the ICECAP-
O index values (n = 1174) is similar (Figure 4).
Performance of Mapping Models
OLS models failed to reproduce many features of the
target distributions. For example, the linear model with
the lowest mean square error (0.231) for EQ-5D-3L at
baseline had a higher MSE than that reported in Table 3
for mixture models applied to this outcome (0.229), and
likewise had a higher mean average error (0.161 com-
pared with 0.160 in the mixture models). Of more conse-
quence is that the lowest predicted value of EQ-5D-3L
value was 0.497 (compared with an observed minimum
of 20.181) and a maximum of 0.995 compared with 1 in
the observed data. Moreover, these models predicted val-
ues outside the feasible permitted range; approximately
3% of values were predicted to be in the ‘‘gap’’ between
0.883 and 1. The distribution of predicted values was
Figure 1 Responses to Cat-PROM5 at baseline and follow-up.
Table 2 Correlation Between Quality of Life/Capability and Cat-PROM5
Baseline Follow-Up
EQ-5D-3L EQ-5D-5L ICECAP-O EQ-5D-3L EQ-5D-5L ICECAP-O
Spearman’s rho 20.20 20.30 20.35 20.20 20.26 20.29
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approximately symmetric, unlike the skewed and multi-
modal values of the observed data. The same types of
issue were observed from linear models of EQ-5D-5L
and ICECAP-O at baseline and follow-up.
Adjusted limited dependent variable mixture models
performed better than OLS models on all criteria for
both versions of EQ-5D, and for ICECAP-O. Our focus
hereon is therefore on the performance of the mixture
models.
No single mixture model was superior when assessed
against all performance criteria. Generally, models that
included some covariates and which allowed the prob-
ability of class membership to depend on covariates per-
formed better than simpler models. Three-component
models outperformed two-component models on almost
all performance criteria, except for EQ-5D-5L at follow-
up, for which the best performing two-component model
had very slightly better error performance than the three-
component model.
Inspection of graphical output revealed that most mix-
ture models had good fit to target distributions. Models
with relatively low error scores also had good face valid-
ity, with the associations between target questionnaires
and Cat-PROM5 having the expected sign.
There is a risk that identifying a single model as the
‘‘winner’’ creates an artificial distinction between this
and other models despite similarities of performance.
However, given that future analysts may nevertheless
require a specific set of parameter estimates to make a
mapping between Cat-PROM5 and the three target
questionnaires modelled here, Table 3 presents models
with the lowest RMSE, provided that these models had
good face validity, and that at least one other criterion
(AIC, BIC, MAE) was better than the median perfor-
mance (across all estimated models for the target out-
come concerned) for that criterion.
The associated parameter estimates and associated
covariance matrices for these five models are available as
Figure 2 Responses to EQ-5D-3L at baseline and follow-up.
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spreadsheets in supplementary material available at
https://github.com/pdixon-econ/cat-prom5-mixture-map
ping. Table 4 shows further selected performance metrics
from these models.
The results indicate accurate prediction of the mean
and standard deviation of all outcomes. No values were
reported outside feasible ranges for any of these models.
There is some modest overprediction at the tails of all
outcome distributions, which can also be seen when com-
paring predicted values from simulated data (using 1000
simulated values from the estimated mixture models) to
actual data on each target outcome variable (see Figures
A1 and A2 in supplementary material).
Despite this modest overprediction at the extremes of
the distributions, there is a good fit between the simu-
lated data produced by each model and the actual data.
Finally, 95% confidence intervals by decile of the Cat-
PROM5 overlap those of predicted values for all models—
see supplementary material for a graphical summary of this
output.
Overall, adjusted limited dependent variable mixture
models offer a good to excellent fit. In this cohort,
selected models reproduced important features of target
outcome distributions. The models reflected mean values
by decile of Cat-PROM5, reproduced the skewness
and multimodality of target outcome distributions, and
did not predict any values outside feasible ranges.
Supplementary material (available at https://github.com/
pdixon-econ/cat-prom5-mixture-mapping) contains Stata
code, based on Gray et al.,22 to implement the mapping
algorithm in other samples.
Discussion
This study reports the findings of the first mapping from
the new Cat-PROM5 instrument to EQ-5D-3L, EQ-5D-
5L, and ICECAP-O measures. The mapping algorithms
will be relevant to clinical and research settings that
involve cataracts, one of the most prevalent eye condi-
tions in the world. The algorithms may be used on
Figure 3 Responses to EQ-5D-5L at baseline and follow-up.
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preoperative and postoperative patients. Parameter esti-
mates and covariance matrices are available in supple-
mentary material (https://github.com/pdixon-econ/cat-
prom5-mixture-mapping) to allow other researchers to
use these estimates.
This is also, to our knowledge, the first set of mapping
algorithms to use adjusted limited dependent variable
mixture models with ICECAP-O as an outcome, and one
of the first studies to map from a disease specific measure
to ICECAP-O.34 The results and methodology may also
be relevant to mapping studies in other disease areas where
patients report substantial differences in preference-based
outcomes before and after clinical interventions. This may
include, for example, before-and-after outcome assess-
ments in relation to joint replacements.
We note at this juncture that the development of a
successful mapping algorithm for Cat-PROM5 does not
mean that the target preference-based genetic instru-
ments we studied are necessarily the most appropriate
means of measuring outcomes in patients undergoing
cataract surgery. This kind of assessment is beyond the
scope of our work. However, the mapping algorithms
will permit the calculation of quality-adjusted life years
and other measures intended to offer comparable infor-
mation on effectiveness and cost-effectiveness across dif-
ferent types of intervention, health conditions, and
patient groups. These outcome measures are fundamen-
tal to health technology appraisal and reimbursement deci-
sions, and the mapping algorithm extends the domains in
which the Cat-PROM5 instrument may be used.
Strengths
We reviewed guidelines for conducting12 and reporting11
mapping studies. Where possible and appropriate, we
sought to adhere to these guidelines in the analysis and
presentation of our models. We paid particular attention
to the selection of modelling approaches that had been
demonstrated to perform well in other disease areas and
for other disease-specific instruments.
Figure 4 Responses to ICECAP-O at baseline and follow-up.
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To this end, we focused on adjusted dependent vari-
able limited dependent mixture models. These models
offer a flexible basis for developing mapping algorithms.
Mapping using adjusted limited dependent variable mix-
ture models offered excellent fit to each target outcome
measure. The mixture model approach offers much more
accurate prediction across the distribution of the target
outcomes than linear models, which will be relevant in
future modelling exercises where a range of possible
health states may be included in, for example, decision-
analytic models used for cost-effectiveness analysis.
Limitations
Differences in the distributions of each measure between
baseline and follow-up meant that using one or other of
these samples as a validation sample would be inap-
propriate, since the model specifications chosen at base-
line was not likely to be suitable for the follow-up data.
For example, the proportion of patients in perfect health
increased by more than 50% for EQ-5D-5L between
baseline and follow-up.
While validation on external samples is not necessarily
required by ISPOR (International Society for Pharmaco-
economics and Outcomes Research) guidelines,12 there
would be merit in exploring the robustness of these mod-
els on other, larger datasets that may become available
in the future. In the absence of data from larger external
studies, we suggest that those interested in mapping from
Cat-PROM5 to the target outcome measures distinguish
between preoperative and postoperative cataract patients
for the reasons described above.
The analysis involved fitting over 900 different models,
excluding preliminary data investigations and modelling.
No single model was superior on all assessment criteria,
and many of the better performing models were practi-
cally indistinguishable when assessing graphical outputs.
It is possible that, by emphasizing RMSE as the principal
means of discriminating between the many mixture mod-
els that had good fit, we have overlooked other models
that may be more suitable in other patient cohorts.
More generally, it is not possible to know if the esti-
mation models are misspecified. There is a tradeoff
between including many potentially relevant covariates
and allowing the mapping algorithm to be general
enough for use in context where less rich patient-level
data are available. However, it is reassuring that many
mixture models that relied on individual patient data (in
some form) on sex, age, and diabetic status offered (at a
minimum) satisfactory performance.
There is no guarantee that global rather than local
optima were identified in the mixture models, despite
efforts to use a variety of approaches to assess the sensi-
tivity of results to different starting models. Convergence
was not achieved for any specification of EQ-5D-3L at
follow-up. This requires exploration in larger samples of
cataract patients.
Between the end of data collection in the Predict-CAT
cohort and the writing of this report, a quality review of
the valuation process for the EQ-5D-5L questionnaire
was published.35 This review raised a number of con-
cerns, which led to NICE (National Institute for Health
and Care Excellence) issuing a position statement recom-
mending that this valuation not be used by organizations
preparing submissions to NICE. The future of the valua-
tion is uncertain. We note that mixture modelling
between Cat-PROM5 and EQ-5D-5L using the current
valuation for England offers excellent model fit, but
changes to valuation would change the parameters of
this mapping model.
Conclusion
Mapping to EQ-5D-3L, EQ-5D-5L, and ICECAP-O
from the newly developed Cat-PROM5 instrument for
patients eligible for cataract surgery is feasible. Mapping
using adjusted limited dependent variable mixture models
offered good to excellent fit for preoperative and post-
operative patient cohorts.
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